Laurence Fayadat-Dilman

This inventor holds 16 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents, primarily in Monoclonal Antibodies. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp + Dohme B.v., Zymeworks Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence Fayadat-Dilman. Retrieved from https://idiyas.com/inventor/laurence-fayadat-dilman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Palo Alto, CA (US) (2021)
Sunnyvale, CA (US) (2019 - 2024)

Company Filing History:

16 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 55

Merck Sharp + Dohme B.v.

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Immunoglobulin-like Transcript 3

Anti-PD-1

Anti-TIGIT

Anti-LAG3

Bispecific Antibodies

Antigen-binding Fragments

Anti-CD27

Therapeutic Applications

Cancer Treatment

Immune Modulation

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441792 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof (2025-10-14),

2. 12435133 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof (2025-10-07),

3. 12122834 - Anti-PD-1 antibodies (2024-10-22),

4. 12102681 - Anti-LAG3 antibodies and antigen-binding fragments (2024-10-01),

5. 12102680 - Anti-TIGIT antibodies (2024-10-01),

6. 11958902 - Anti-TIGIT antibodies (2024-04-16),

7. 11278620 - Anti-LAG3 antibodies and antigen-binding fragments (2022-03-22),

8. 11207406 - Anti-LAG3 antibodies and antigen-binding fragments (2021-12-28),

9. 11111297 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof (2021-09-07),

10. 11072658 - Anti-PD-1/LAG3 bispecific antibodies (2021-07-27),

11. 11045547 - Anti-LAG3 antibodies and antigen-binding fragments (2021-06-29),

12. 10898571 - Anti-LAG3 antibodies and antigen-binding fragments (2021-01-26),

13. 10766957 - Anti-TIGIT antibodies (2020-09-08),

14. 10618958 - Anti-TIGIT antibodies (2020-04-14),

15. 10556957 - Anti-CD27 antibodies (2020-02-11),

Title: The Innovative Mind of Laurence Fayadat-Dilman

Introduction: Laurence Fayadat-Dilman is a visionary inventor based in Sunnyvale, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Laurence Fayadat-Dilman holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Laurence Fayadat-Dilman has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of what is possible in the world of innovation.

Collaborations: Throughout his career, Laurence Fayadat-Dilman has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Laurence Fayadat-Dilman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.